The U.S. Food and Drug Administration is in the midst of hearings to assess how to regulate homeopathic medicine and practice for the first time in a quarter-century.  

More than half a dozen proponents of homeopathy - which is based on the belief that disease symptoms can be cured by minute doses of a remedy that would, in larger amounts, produce in healthy persons symptoms similar to the disease - are testifying before the FDA, along with skeptics who think such remedies should be subjected to the same scrutiny as over-the-counter drugs.

Would that mean homeopathy would be subjected to clinical trials? How should labeling change? Is enough known about the side effects of homeopathic products?

Guests:

Michael De Dora, director of the Center for Inquiry's Office of Public Policy; a non-profit organization advocating for science-based policy; De Dora provided testimony to the FDA hearings on homeopathy oversight

Paul Herscu, ND & MPH, Licensed Naturopathic Physician and published author who writes frequently on issues in homeopathy